http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2634634-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96ec3985e3ce9b24614fb87bf51a4f12 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0044 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-0081 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0083 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J7-0085 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
| filingDate | 2010-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4626592dc7703e1c33bc24bc55cd5d9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b23392492c973da17b1c09bccd92b151 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae397512ef95fc7270af27b09ee08449 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88393d0e89747783bceac6dec0087f04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_219ac4c16b5d7a42c0e847dc6a523fc5 |
| publicationDate | 2017-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2634634-T3 |
| titleOfInvention | Derivatives of 17-hydroxy-17-pentafluoroethyl-estra-4,9 (10) -dien-11-acyloxyalkylenephenyl, process for its preparation and use for the treatment of diseases |
| abstract | Compound of formula I ** Formula ** in which X signifies oxygen, a group NOR3 or> = NNHSO2R3, R1 signifies C1-C10 alkyl, (CH2) nY or CHR4NR5PG, R2 signifies hydrogen or C1-C10 alkyl, R3 signifies hydrogen, C1-C10 alkyl, aryl or C7-C20 aralkyl, n means 1 to 10, Y means hydrogen, aryl, heteroaryl R4, R5 independently of one another hydrogen, C1-C10 alkyl, C7-C10 aralkyl, or together are a (CH2) m- group or a CH2CHOHCH2 group, m stands for 3 or 4 and PG stands for hydrogen or an amino protecting group and its salts, solvates or solvates of the salts, including all crystalline modifications, the α-, β- or γ-cyclodextrinclarates, as well as compounds encapsulated with liposomes in which Aryl represents an aromatic mono- to tricyclic carbocyclic radical, substituted or unsubstituted, which may be substituted one or more times with halogen (F, Cl, Br, I) , OH, O-alkyl, CO2H, CO2 alkyl, NH2, NH (C1-C10 alkyl), N (C1-C10 alkyl ) 2, in particular groups N (CH3) 2, NO2, N3, CN, C1-C10 alkyl, C2-C10 alkylene, C2-C10 alkynyl, perfluoro-C1-C10 alkyl, C1-C10 acyl, C1-C10 acyloxy. Heteroaryl represents an aromatic, mono- or bicyclic radical with generally 5 to 10 ring atoms and up to 5 heteroatoms of the S, O and N series, for example, which may be substituted once with C1-C4 alkyl. Aralkyl represents aralkyl groups, and may be substituted one or more times by halogen, OH, O groups, alkyl, CO2H, alkyl-CO2, NH2, NH (C1-C10 alkyl), N (C1-C10 alkyl) 2, NO2, N3 , CN, C1-C20 alkyl, C1-C10 perfluoroalkyl, C1-C20 acyl, C1-C20 acyloxy groups. |
| priorityDate | 2009-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.